LifeMD (LFMD) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.46, +3.80% vs the prior close of $2.37.
- Volume 737.00K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LFMD jumps 3.8% to $2.46. Closed at $2.46, +3.80% vs the prior close of $2.37. Day range $2.34β$2.50, opened at $2.36.
LFMD daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β LFMD jumps 3.8% to $2.46
- Closed at $2.46, +3.80% vs the prior close of $2.37. Day range $2.34β$2.50, opened at $2.36.
- Volume was 737.00K shares, 0.8x its 50-day average of 879.37K.
- Price is -20.1% vs its 50-day average ($3.08) and -34.5% vs its 200-day average ($3.75).
- 52-week range $2.34β$6.53; today's close sits at 3% of that range, 62.3% below the 52-week high.
Oct 14, 2026 β LFMD slides 4.0% to $2.37, a 52-week low, 5 down days in a row
- Closed at $2.37, -4.05% vs the prior close of $2.47. Day range $2.36β$2.48, opened at $2.47.
- Volume was 669.60K shares, 0.8x its 50-day average of 878.81K.
- Price is -23.6% vs its 50-day average ($3.10) and -36.9% vs its 200-day average ($3.76).
- 52-week range $2.36β$6.53; today's close sits at 0% of that range, 63.7% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 β LFMD slides 3.1% to $2.47, a 52-week low, 4 down days in a row
- Closed at $2.47, -3.14% vs the prior close of $2.55. Day range $2.46β$2.57, opened at $2.55.
- Volume was 718.20K shares, 0.8x its 50-day average of 876.44K.
- Price is -21.2% vs its 50-day average ($3.13) and -34.4% vs its 200-day average ($3.76).
- 52-week range $2.46β$6.53; today's close sits at 0% of that range, 62.2% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 β LFMD slides 3.0% to $2.55, a 52-week low, 3 down days in a row
- Closed at $2.55, -3.04% vs the prior close of $2.63. Day range $2.53β$2.65, opened at $2.65.
- Volume was 626.40K shares, 0.7x its 50-day average of 875.38K.
- Price is -19.3% vs its 50-day average ($3.16) and -32.4% vs its 200-day average ($3.77).
- 52-week range $2.53β$6.68; today's close sits at 0% of that range, 61.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 β LFMD dips 0.8% to $2.63, a 52-week low
- Closed at $2.63, -0.75% vs the prior close of $2.65. Day range $2.58β$2.68, opened at $2.66.
- Volume was 620.10K shares, 0.7x its 50-day average of 876.23K.
- Price is -17.2% vs its 50-day average ($3.18) and -30.4% vs its 200-day average ($3.78).
- 52-week range $2.56β$6.69; today's close sits at 2% of that range, 60.7% below the 52-week high.
Oct 8, 2026 β LFMD slides 5.0% to $2.65, a 6-month low
- Closed at $2.65, -5.02% vs the prior close of $2.79. Day range $2.62β$2.77, opened at $2.77.
- Volume was 929.90K shares, 1.1x its 50-day average of 871.54K.
- Price is -17.1% vs its 50-day average ($3.20) and -29.9% vs its 200-day average ($3.78).
- 52-week range $2.56β$6.83; today's close sits at 2% of that range, 61.2% below the 52-week high.
Oct 7, 2026 β LFMD rises 2.2% to $2.79
- Closed at $2.79, +2.20% vs the prior close of $2.73. Day range $2.68β$2.86, opened at $2.70.
- Volume was 509.80K shares, 0.6x its 50-day average of 880.12K β lighter than usual.
- Price is -13.3% vs its 50-day average ($3.22) and -26.2% vs its 200-day average ($3.78).
- 52-week range $2.56β$6.99; today's close sits at 5% of that range, 60.1% below the 52-week high.
Oct 6, 2026 β LFMD rises 0.4% to $2.73
- Closed at $2.73, +0.37% vs the prior close of $2.72. Day range $2.71β$2.81, opened at $2.75.
- Volume was 444.50K shares, 0.5x its 50-day average of 891.92K β lighter than usual.
- Price is -15.7% vs its 50-day average ($3.24) and -27.9% vs its 200-day average ($3.78).
- 52-week range $2.56β$7.12; today's close sits at 4% of that range, 61.7% below the 52-week high.
Oct 5, 2026 β LFMD dips 0.7% to $2.72, a 6-month low, 3 down days in a row
- Closed at $2.72, -0.73% vs the prior close of $2.74. Day range $2.67β$2.86, opened at $2.86.
- Volume was 801.60K shares, 0.9x its 50-day average of 891.08K.
- Price is -16.6% vs its 50-day average ($3.26) and -28.2% vs its 200-day average ($3.79).
- 52-week range $2.56β$7.32; today's close sits at 3% of that range, 62.8% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 β LFMD slides 3.9% to $2.74, a 6-month low
- Closed at $2.74, -3.86% vs the prior close of $2.85. Day range $2.73β$2.94, opened at $2.86.
- Volume was 708.30K shares, 0.8x its 50-day average of 901.79K.
- Price is -16.5% vs its 50-day average ($3.28) and -27.7% vs its 200-day average ($3.79).
- 52-week range $2.56β$7.32; today's close sits at 4% of that range, 62.6% below the 52-week high.
LFMD latest news & SEC filings
Every SEC filing by or about LFMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 25, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4/A β Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $47.28M (prior year $49.02M) (-3.5% vs Jun 30, 2025)
- Net income: -$7.08M (prior year -$1.62M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.05) (loss widened vs Jun 30, 2025)
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade LFMD
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 9, 2026, Nov 17, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.49% (largest 7.6%).
- Liquidity: about 718.31K shares (β$1.77M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.46 vs a range of $2.34β$6.53 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Jessica Friedeman sold 15,000 shares on Dec 9, 2025.
- Latest filings: 8-K Sep 15, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 48.20M shares outstanding (Aug 4, 2026), +1.7% vs a year earlier.
- Listing: Nasdaq Β· industry: Services-Offices & Clinics of Doctors of Medicine.
LFMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.36 | 2.50 | 2.34 | 2.46 | 737.00K |
| Oct 14, 2026 | 2.47 | 2.48 | 2.36 | 2.37 | 669.60K |
| Oct 13, 2026 | 2.55 | 2.57 | 2.46 | 2.47 | 718.20K |
| Oct 12, 2026 | 2.65 | 2.65 | 2.53 | 2.55 | 626.40K |
| Oct 9, 2026 | 2.66 | 2.68 | 2.58 | 2.63 | 620.10K |
| Oct 8, 2026 | 2.77 | 2.77 | 2.62 | 2.65 | 929.90K |
| Oct 7, 2026 | 2.70 | 2.86 | 2.68 | 2.79 | 509.80K |
| Oct 6, 2026 | 2.75 | 2.81 | 2.71 | 2.73 | 444.50K |
| Oct 5, 2026 | 2.86 | 2.86 | 2.67 | 2.72 | 801.60K |
| Oct 2, 2026 | 2.86 | 2.94 | 2.73 | 2.74 | 708.30K |
| Oct 1, 2026 | 2.90 | 2.91 | 2.83 | 2.85 | 712.00K |
| Sep 30, 2026 | 2.90 | 3.00 | 2.85 | 2.90 | 725.50K |
| Sep 29, 2026 | 2.94 | 2.99 | 2.85 | 2.88 | 809.50K |
| Sep 28, 2026 | 2.97 | 3.04 | 2.88 | 2.93 | 601.30K |
| Sep 25, 2026 | 2.95 | 3.01 | 2.90 | 2.97 | 767.80K |
| Sep 24, 2026 | 3.04 | 3.07 | 2.90 | 2.91 | 855.40K |
| Sep 23, 2026 | 3.28 | 3.28 | 3.03 | 3.05 | 816.60K |
| Sep 22, 2026 | 3.26 | 3.36 | 3.23 | 3.30 | 506.00K |
| Sep 21, 2026 | 3.25 | 3.31 | 3.19 | 3.23 | 622.80K |
| Sep 18, 2026 | 3.19 | 3.31 | 3.16 | 3.22 | 1.18M |
About LifeMD
LifeMD (LFMD) is listed on the Nasdaq and classified by the SEC under βServices-Offices & Clinics of Doctors of Medicineβ. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 948320.
LFMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Joseph Ditrolio | Director | Aug 13, 2026 |
| Joan Larovere | Director | Aug 18, 2026 |
| Calum Archibald Macrae | Director | Aug 13, 2026 |
| Roberto Simon | Director | Aug 13, 2026 |
| John R Jr Strawn | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jessica Friedeman | Chief Marketing Officer | Dec 11, 2025 |
| Atul Kavthekar | Chief Financial Officer | May 13, 2026 |
| Christopher A Pisano | Chief Marketing Officer | Apr 1, 2026 |
| Umesh Sripad | Chief Technology Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 9, 2025 | Jessica Friedeman | Sale | 15,000 | $3.61 |
LFMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $194.06M | $14.35M | 0.25 | $8.28M |
| Dec 31, 2024 | $154.82M | $-21.41M | -0.60 | $17.51M |
| Dec 31, 2023 | $152.55M | $-20.60M | β | $8.82M |
| Dec 31, 2022 | $119.03M | $-45.54M | β | $-22.94M |
| Dec 31, 2021 | $92.88M | $-60.90M | β | $-33.09M |
Latest balance sheet: total assets $59.89M, total liabilities $51.93M, cash $36.23M (as of Jun 30, 2026).
LFMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $3.68 |
| May 6, 2026 | 8-K Item 2.02 (results) | $5.27 |
| Mar 9, 2026 | 8-K Item 2.02 (results) | $3.12 |
| Nov 17, 2025 | 8-K Item 2.02 (results) | $4.73 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $11.84 |
| May 6, 2025 | 8-K Item 2.02 (results) | $7.76 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $4.27 |
| Jan 19, 2022 | 8-K Item 2.02 (results) | β |
| May 13, 2021 | 8-K Item 2.02 (results) | β |
| Apr 19, 2021 | 8-K Item 2.02 (results) | β |
| Apr 1, 2021 | 8-K Item 2.02 (results) | β |
| Jan 19, 2021 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Offices & Clinics of Doctors of Medicine
Hims & Hers Health (HIMS)Teladoc Health (TDOC)Starling Oncology (STLN)Basel Medical (BMGL)Auna (AUNA)SBC Medical (SBC)Airsculpt Technologies (AIRS)Concord Medical Services (CCM)Westin Acquisition (WSTN)LifeMD (LFMDP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LFMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.